Literature DB >> 3437004

High-performance liquid chromatography of ciprofloxacin and its metabolites in serum, urine and sputum.

C M Myers1, J L Blumer.   

Abstract

A versatile and sensitive method requiring no internal standard was developed for quantitating ciprofloxacin in serum, urine and sputum by high-performance liquid chromatography with fluorescence detection. Acetonitrile and chloroform were employed to remove protein and lipophilic substances from an aqueous, ciprofloxacin-containing sample layer. The proportions of acetonitrile and 0.1 M potassium phosphate, pH 2.5, in the mobile phase were varied to suit the purpose of the assay. For the routine determination of ciprofloxacin pharmacokinetics, isocratic 19% acetonitrile was used. A gradient from 15 to 35% acetonitrile was chosen to show the appearance of metabolites which formed during the biodisposition of ciprofloxacin. In the latter case urine samples were diluted for assay and protein was precipitated from serum samples with trichloroacetic acid. Four fluorescent metabolites were observed in all patient specimens, and with tandem ultraviolet detection two additional ultraviolet-absorbing metabolites were readily found in urine specimens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3437004     DOI: 10.1016/0378-4347(87)80448-6

Source DB:  PubMed          Journal:  J Chromatogr


  4 in total

1.  Effects of enzyme supplementation on oral absorption of ciprofloxacin in patients with cystic fibrosis.

Authors:  G Mack; P J Cooper; N Buchanan
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

2.  Determination of temafloxacin, sarafloxacin, and difloxacin in bulk drug and dosage forms by high-performance liquid chromatography.

Authors:  J F Bauer; L Elrod; J R Fornnarino; D E Heathcote; S K Krogh; C L Linton; B J Norris; J E Quick
Journal:  Pharm Res       Date:  1990-11       Impact factor: 4.200

3.  The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing.

Authors:  E J Begg; R A Robson; D A Saunders; G G Graham; R C Buttimore; A M Neill; G I Town
Journal:  Br J Clin Pharmacol       Date:  2000-01       Impact factor: 4.335

4.  A novel validated stability indicating high performance liquid chromatographic method for estimation of degradation behavior of ciprofloxacin and tinidazole in solid oral dosage.

Authors:  Bhupendrasinh K Vaghela; Surendra Singh Rao
Journal:  J Pharm Bioallied Sci       Date:  2013-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.